Great Work MSB. I am very relieved.
Why do I feel like the acceptance today of the resubmitted BLA which had to address the CRL items is the harder part and the FDA approval is now just an easier formality.
I guess as it’s taken years just to address the CRL items and that was long and hard, I believe the FDA already know REM-L works, it just had to be fully detailed and quantified why it does and how it is safe and consistent.
The approval seems easy from here.
Anyone else feel a bit like that?
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-281
-
- There are more pages in this discussion • 727 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.035(3.65%) |
Mkt cap ! $1.156B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | $1.03 | 96.5¢ | $4.490M | 4.493M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8174 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.0¢ | 2738 | 1 |
View Market Depth
| Last trade - 15.59pm 14/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |